Home
ACTL Immunotherapy
Functional Mechanism
Advantages
Safety
Indications
Protocols
Steps
Patents
Translational Medicine
Treatment & Prevent
Conditions
Case Studies
Cooperative Hospital
Early Detection
Prevention
Nursing & Care
News
Partnership
About Us
Company Introduction
Our Culture
Milestones
Qualification & Honor
Team of Experts
Activities
Jobs
Contact Us
简体
繁体
英文
Coperate News
Coperate News
Industrial News
Policies & Regulations
08-11 2016
The 7th Northern Regional Lymphoma Symposium was held in Beijing
On August 4, 2016, in the conference hall of Beijing Haoyuan Jianguo Hotel, the "Seventh Nor...
Details
04-08 2016
Ishikoning obtained AAA credit rating enterprise certification
Recently, Shenzhen Yishi Kangning Biotechnology Co., Ltd. has obtained the enterprise credit ...
Details
03-14 2016
ACTL technology treatment of lung cancer multi-center project kick-off meeting was successfully held in Nanjing, Jiangsu
In March of Yangchun, everything recovers, and the land of Jiangsu is full of vitality. On Mar...
Details
03-05 2016
ACTL's anti-tumor immune technology was fully signed and launched in Jiangsu Province!
Recently, the Jiangsu Provincial Health and Family Planning Commission and other relevant uni...
Details
02-25 2016
ACTL technology settled in Hefei, serving patients in Anhui and surrounding areas!
After more than a year of exchanges and preparations, ACTL targeted anti-tumor cell immune tech...
Details
First
<<
3
4
5
6
7
>>
10
